Eight-year-old urges company to lower price of cystic fibrosis drug
An eight-year-old boy with cystic fibrosis has urged a pharmaceutical company to lower the price of a drug so it can be made available on the NHS. Orkambi received its
Read MoreAn eight-year-old boy with cystic fibrosis has urged a pharmaceutical company to lower the price of a drug so it can be made available on the NHS. Orkambi received its
Read MoreA charity has condemned a decision by health officials to reject a drug to treat a rare genetic disorder which can mean that affected children do not live to their
Read MoreA drug that slows the affects of multiple sclerosis (MS) has been recommended for treatment on the NHS. The National Institute for Health and Care Excellence (Nice) has published draft
Read MoreResearchers have criticised the rejection of a prostate cancer drug they hailed as a “game changer”. The Institute of Cancer Research (ICR) said thousands of men a year could be
Read MoreUp to 850 women in England and Wales could benefit from a targeted pill that treats ovarian cancer after it was approved for use on the NHS through the Cancer
Read MoreHundreds of children plagued by a life-shortening disease have written to the Prime Minister begging her for access to a “life-saving” drug. More than 1,000 personal letters are to be
Read MoreOnly one in seven women who are at high risk of breast cancer are taking a preventative drug, a new study suggests. Researchers found that six in seven women with
Read MoreHealth officials have reversed a decision over whether a genetic test for breast cancer patients should be used by the NHS. The Oncotype DX test was provisionally rejected for use
Read MoreHealth officials are set to give the green light to a new treatment for a condition which has not seen any advances in almost six decades. The National Institute for
Read MoreSharon Jeffreys from the Mental Health Intensive Support Team, NHS Improvement discusses the National Institute for Health and Care Excellence (NICE)’s learning disabilities guideline and how organisations can work to
Read More